2011
DOI: 10.1038/ncb2264
|View full text |Cite
|
Sign up to set email alerts
|

A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly

Abstract: TP53(tumour protein 53) is one of the most frequently mutated genes in human cancer and its role during cellular transformation has been studied extensively. However, the homeostatic functions of p53 are less well understood. Here, we explore the molecular dependency network of TP53 through an RNAi-mediated synthetic interaction screen employing two HCT116 isogenic cell lines and a genome-scale endoribonuclease-prepared short interfering RNA library. We identify a variety of TP53 synthetic interactions unmaski… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
53
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 74 publications
(53 citation statements)
references
References 68 publications
0
53
0
Order By: Relevance
“…RNA interference (RNAi) has been used successfully in high-throughput screens to identify potential drug targets (Gargiulo et al, 2013;Liu et al, 2013). In particular, RNAi has been used to identify putative tumor suppressors in forward genetic screens (Westbrook et al, 2005;Krastev et al, 2011;Iorns et al, 2012). Recently, our laboratory performed RNAi screens designed to specifically target kinases and phosphatases, characterizing PTPN12 as a tumor suppressor (Sun et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…RNA interference (RNAi) has been used successfully in high-throughput screens to identify potential drug targets (Gargiulo et al, 2013;Liu et al, 2013). In particular, RNAi has been used to identify putative tumor suppressors in forward genetic screens (Westbrook et al, 2005;Krastev et al, 2011;Iorns et al, 2012). Recently, our laboratory performed RNAi screens designed to specifically target kinases and phosphatases, characterizing PTPN12 as a tumor suppressor (Sun et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Only with the development of RNA interference have systematic large-scale genetic interaction screens become feasible in human cancer cell lines. 17,18 However, despite the artificial cellular background that cultured cancer cells provide, such screens have been rarely carried out in primary cells. In the present study, we report a pooled genome-wide, shRNA-based Runx1 genetic interaction screen in primary mouse hematopoietic cells.…”
Section: Introductionmentioning
confidence: 99%
“…cells without effecting the p53-negative cells. 5 This finding suggests that the identified genes present specific checkpoints of the ribosome assembly pathway that are monitored by p53. When the amount of these proteins ceases in the cell (in this case because of their knockdown), p53 is activated, which, in turn, stops proliferation and ultimately leads to cell death.…”
Section: Ribosome Biogenesis and P53mentioning
confidence: 87%
“…It turns out that NOLC1 levels are dependent on basal p53 activity, thus revealing a homeostatic function of p53 to support ribosome biogenesis in unstressed cells. 5 Furthermore, when cells experience stress (e.g., DNA damage or treatment with p53 agonist Nutlin-3a), NOLC1 levels are downregulated, showing that this homeostatic function can be turned into a stress response. In consequence, both UNRIP and NOLC1 converge in snoRNP assembly, explaining the selective dependency of p53-negative cells on UNRIP expression (Fig.…”
Section: Ribosome Biogenesis and P53mentioning
confidence: 99%